These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30842375)
1. Polysplenia Syndrome as a Risk Factor for Early Progression of Pulmonary Hypertension. Shibata A; Mori H; Kodo K; Nakanishi T; Yamagishi H Circ J; 2019 Mar; 83(4):831-836. PubMed ID: 30842375 [TBL] [Abstract][Full Text] [Related]
2. Defects in laterality with emphasis on heterotaxy syndromes with asplenia and polysplenia: an autopsy case series at a single institution. Burton EC; Olson M; Rooper L Pediatr Dev Pathol; 2014; 17(4):250-64. PubMed ID: 24735181 [TBL] [Abstract][Full Text] [Related]
3. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685 [TBL] [Abstract][Full Text] [Related]
4. Portopulmonary hypertension secondary to congenital extrahepatic portosystemic shunt with heterotaxy and polysplenia: a cause of sudden death in an infant. Kobayashi D; Edwards HD; Singh J; Nadkarni MD; Lantz PE; Cook AL Pediatr Pulmonol; 2011 Oct; 46(10):1041-4. PubMed ID: 21520436 [TBL] [Abstract][Full Text] [Related]
5. Bodily isomerism is an independent risk factor for pulmonary hypertension in adults with congenital heart disease. Loomba RS; Aggarwal S; Arora RR; Anderson R Ther Adv Respir Dis; 2016 Jun; 10(3):194-9. PubMed ID: 26944361 [TBL] [Abstract][Full Text] [Related]
6. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1. Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785 [TBL] [Abstract][Full Text] [Related]
7. Outcomes in adults with congenital heart disease and heterotaxy syndrome: A single-center experience. Broda CR; Salciccioli KB; Lopez KN; Ermis PR; Moodie DS; Dickerson HA Congenit Heart Dis; 2019 Nov; 14(6):885-894. PubMed ID: 31617655 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease. Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131 [TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatation. Law YM; Mack CL; Sokol RJ; Rice M; Parsley L; Ivy D Pediatr Transplant; 2011 Dec; 15(8):E162-8. PubMed ID: 20565694 [TBL] [Abstract][Full Text] [Related]
11. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects. Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959 [TBL] [Abstract][Full Text] [Related]
12. Increased postoperative respiratory complications in heterotaxy congenital heart disease patients with respiratory ciliary dysfunction. Harden B; Tian X; Giese R; Nakhleh N; Kureshi S; Francis R; Hanumanthaiah S; Li Y; Swisher M; Kuehl K; Sami I; Olivier K; Jonas R; Lo CW; Leatherbury L J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1291-1298.e2. PubMed ID: 23886032 [TBL] [Abstract][Full Text] [Related]
13. [Screening study of pulmonary arterial hypertension in patients with congenital heart diseases]. Sun YJ; Pang KJ; Zeng WJ; Wang H; He JG Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1091-4. PubMed ID: 22781765 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease. Muneuchi J; Ochiai Y; Masaki N; Okada S; Iida C; Sugitani Y; Ando Y; Watanabe M Heart Vessels; 2019 Mar; 34(3):470-476. PubMed ID: 30225809 [TBL] [Abstract][Full Text] [Related]
15. Age is not a good predictor of irreversibility of pulmonary hypertension in congenital cardiac malformations with left-to-right shunt. Hosseinpour AR; Perez MH; Longchamp D; Cotting J; Sekarski N; Hurni M; Prêtre R; Di Bernardo S Congenit Heart Dis; 2018 Mar; 13(2):210-216. PubMed ID: 29071783 [TBL] [Abstract][Full Text] [Related]
16. Fontan Palliation in Patients with Heterotaxy Syndrome: A Five Decade Experience. Stephens EH; Graham G; Dearani JA; Niaz T; Cetta F World J Pediatr Congenit Heart Surg; 2022 Jul; 13(4):436-442. PubMed ID: 35757949 [TBL] [Abstract][Full Text] [Related]
17. Fatal pneumococcal septicemia in a girl with visceral heterotaxy and polysplenia: a case report. von Both I; Pollanen MS Forensic Sci Med Pathol; 2020 Sep; 16(3):519-522. PubMed ID: 32405984 [TBL] [Abstract][Full Text] [Related]
18. Early clinical results of the telemetric adjustable pulmonary artery banding FloWatch-PAB. Bonnet D; Corno AF; Sidi D; Sekarski N; Beghetti M; Schulze-Neick I; Fasnacht M; Le Bret E; Kalangos A; Vouhé PR; von Segesser LK Circulation; 2004 Sep; 110(11 Suppl 1):II158-63. PubMed ID: 15364856 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing survival of patients with heterotaxy syndrome undergoing the Fontan procedure. Culbertson CB; George BL; Day RW; Laks H; Williams RG J Am Coll Cardiol; 1992 Sep; 20(3):678-84. PubMed ID: 1380966 [TBL] [Abstract][Full Text] [Related]
20. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Srivastava D; Preminger T; Lock JE; Mandell V; Keane JF; Mayer JE; Kozakewich H; Spevak PJ Circulation; 1995 Sep; 92(5):1217-22. PubMed ID: 7648668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]